With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...

GlaxoSmithKline LLC (GSK) plans to lay off 150 Cambridge workers. The layoffs come months after GSK said it had planned to ...

Even as it cuts jobs, GSK plans to invest €500 million in R&D, manufacturing and other technology over the next three years to support development of new vaccines.

Close to three months after GlaxoSmithKline revealed that it is making deep cuts in its R&D group in North Carolina as part of a major reorganization in the U.S., the pharma giant detailed plans ...

After a business review unveiled in July—and ahead of new challenges—GlaxoSmithKline is sharpening its jobs ax to cut 650 across its U.S. business. On the block are 450 field sales positions ...

LONDON - GlaxoSmithKline PLC, the world's second-largest drugmaker, said today it is cutting 350 jobs, or around 2 percent of its research staff, as part of an ongoing restructuring plan ...

LONDON (Reuters) - GlaxoSmithKline confirmed on Wednesday it would shed several hundred U.S. commercial jobs and a similar number of research positions as it restructures operations in its biggest ...

LONDON • GlaxoSmithKline said on Wednesday it would shed "several hundred" U.S. commercial jobs and a similar number of research positions as it restructures operations in its biggest market ...

GlaxoSmithKline will eliminate 650 positions nationwide as part of a global cost-cutting program. The company is cutting 100 positions in RTP, 100 in Philadelphia and 450 field sales jobs.